Contract notice
Section I: Contracting
authority
I.1) Name and addresses
Leeds Teaching Hospitals
Moor House, 125 Moor Road
Leeds
LS10 2JQ
UK
Contact person: Mrs Amanda Stephenson
Telephone: +44 1133927016
E-mail: amanda.stephenson1@nhs.net
Fax: +44 1133927019
NUTS: UK
Internet address(es)
Main address: http://www.leedsteachinghospitals.com/
Address of the buyer profile: http://www.leedsteachinghospitals.com/
I.2) Joint procurement
The contract is awarded by a central purchasing body
I.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge at:
https://procontract.due-north.com/Opportunities
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be sent electronically to:
https://procontract.due-north.com/Opportunities
I.4) Type of the contracting authority
Regional or local authority
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
High Tech Homecare Medicines Services - including Lot A Compounded Desferrioxamine
Reference number: DN548640
II.1.2) Main CPV code
85149000
II.1.3) Type of contract
Services
II.1.4) Short description
Framework agreement for the provision of high tech homecare medicines services (including lot A compounded desferrioxamine) to members of the Yorkshire and Humber NHS Pharmaceutical Purchasing Consortium, and other organisations with prior approval only.
This framework will be subject to the release of mini competitions for specific high homecare services.
Services are to be provided in line with the Royal Pharmaceutical Society Professional Standards for Homecare.
This framework agreement will be accessible to all partly or wholly publically funded bodies in the United Kingdom, including Northern Ireland, Scotland, Wales and England. This will include, but is not limited to: Acute; (including their third party providers); Ambulance; Mental Health; Clinical Commissioning Groups; Health and Care Trusts; Area Teams; Local Authorities and Special Health Authorities; HSC in Northern Ireland; NHS Scotland and NHS Wales, including any successor or emerging organisations, which will include but is not limited to the emerging landscape of combined health and social care commissioners and providers.
Eligible participating organisations that have prior approval from the Yorkshire and Humber NHS Pharmaceutical Purchasing Consortium are:-
NHS trusts:
http://www.nhs.uk/ServiceDirectories/Pages/AcuteTrustListing.aspx
Clinical Commissioning Groups: http://www.nhs.uk/ServiceDirectories/Pages/CCGListing.aspx
Area Teams:
http://www.nhs.uk/ServiceDirectories/Pages/AreaTeamListing.aspx
Local Authorities:
https://www.lgbce.org.uk/records-and-resources/local-authorities-in-england
Special health authorities: http://www.nhs.uk/ServiceDirectories/Pages/SpecialHealthAuthorityListing.aspx
HSC in Northern Ireland: http://online.hscni.net/other-hsc-organisations
NHS Scotland: http://www.scot.nhs.uk/organisations/
NHS Wales: http://www.wales.nhs.uk/ourservices/directory
For the avoidance of doubt, any successor bodies of any of the above entities shall be entitled to place Orders and shall be deemed Participating Authorities for the purposes of this Framework Agreement.
II.1.6) Information about lots
This contract is divided into lots:
No
II.2) Description
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
Framework agreement for the provision of high tech homecare medicines services (including lot A compounded desferrioxamine) to members of the Yorkshire and Humber NHS Pharmaceutical Purchasing Consortium, and other organisations with prior approval only.
This framework will be subject to the release of mini competitions for specific high homecare services.
Services are to be provided in line with the Royal Pharmaceutical Society Professional Standards for Homecare.
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 48
This contract is subject to renewal: No
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted:
Yes
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.3) Information about a framework agreement or a dynamic purchasing system
The procurement involves the establishment of a framework agreement with several operators.
Justification for any framework agreement duration exceeding 4 years:
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.2) Time limit for receipt of tenders or requests to participate
Date:
22/09/2021
Local time: 12:00
IV.2.4) Languages in which tenders or requests to participate may be submitted
EN
IV.2.6) Minimum time frame during which the tenderer must maintain the tender
Duration in months: 48 (from the date stated for receipt of tender)
IV.2.7) Conditions for opening of tenders
Date:
22/09/2021
Local time: 12:00
Section VI: Complementary information
VI.1) Information about recurrence
This is a recurrent procurement:
No
VI.4) Procedures for review
VI.4.1) Review body
Leeds Teaching Hospitals NHS Trust
Leeds
LS10 2JQ
UK
VI.5) Date of dispatch of this notice
27/07/2021